Cari Gallman - Bristol Myers Squibb

Cari Gallman

Cari Gallman

Executive Vice President, Corporate Affairs

Cari Gallman, executive vice president, Corporate Affairs, is responsible for advancing our company strategy through strategic communications, government relations and policy, corporate social responsibility, corporate marketing and brand reputation, and patient advocacy. In addition, she currently serves as the executive sponsor of the PRIDE Alliance People and Business Resource Group.

Prior to this role, Cari served as chief compliance and ethics officer at BMS, where she championed our culture of Integrity, and drove efforts to ensure our operations are always conducted in compliance with ethical business practices, our Principles of Integrity, and laws and regulations in the global markets in which we operate.

“Our Corporate Affairs team is responsible for fostering trusted relationships with stakeholders to promote, protect, and advance BMS's reputation while strategically positioning the company to thrive in a complex global environment,” says Cari. “I am proud to lead a team that is uniquely equipped to partner and empower every function across the enterprise so that we’re delivering on our patient-centered mission.”

In addition to her Corporate Affairs experience, Cari has almost two decades of combined experience in pharmaceutical law and compliance. She began her legal career in private practice representing pharmaceutical and medical device manufacturers in government enforcement and regulatory matters. In her practice, she regularly advised companies on how to design and implement robust compliance policies to meet business objectives as well as legal needs. She joined the company in 2015 and assumed positions of increasing responsibility, including as head of the legal team supporting the Global Oncology Commercialization and Development organizations.

She earned a bachelor’s degree in political theory from Princeton University, magna cum laude, and a JD from Harvard Law School.

Updated: July 2024


PREVIOUS
NEXT